Tag: Sun Pharma
FDEC commences roll-out of Malaria demonstration project in MP
The Foundation for Disease Elimination and Control of India (FDECINDIA), Indian Council of Medical Research and Govt. of Madhya Pradesh have rolled out Phase 1 of Malaria demonstration project in Mandla, Madhya Pradesh.......
Sun Pharma Science Foundation awards India’s top researchers
Science Award winners were announced and honored by Sun Pharma Foundation for exemplary contribution & research in pharma and medical science at Delhi on April 28th at Delhi......
USFDA to lift import alert on Sun Pharma’s Mohali facility
Regulator will permit the supply of products from Mohali facility inherited by Sun Pharma from Ranbaxy, to the US market .........
BioVoice eMag February 2017 Issue-9 Volume-1
BioVoice eMag February 2017 Issue-9 Volume-1:
This edition of BioVoice in its detailed cover story highlights the gains and pains of the budget 2017. The...
Sun Pharma to acquire Novartis’s Odomzo for global markets
Transaction gives Sun Pharma its first branded oncology product that has marketing approval in over 30 countries globally including US, Europe and Australia....
Research partnerships key to accelerating affordable healthcare!
The collaborative model of health research, open source knowledge sharing besides right medical skills to human resources....
Sun Pharma & ICGEB to jointly develop affordable ‘Made in India’...
While the Sun Pharma will fund the development programme of the dengue vaccine by the ICGEB, it will get exclusive rights over commercialization.....
Sun Pharma achieves breaking results for its Psoriasis drug
The company has achieved primary end point in both Phase-3 studies in patients with moderate-to-severe plaque Psoriasis...
Lupin scales new heights in India’s top pharma reputation list
There were 41 domestic and 17 international pharmaceutical brands listed in the study by BlueBytes conducted in association with TRA Research....
Spain’s Almirall to commercialize Sun Pharma’s Psoriasis drug in Europe
Under terms of the license agreement, the Spanish firm, Almirall will pay Sun Pharma an initial upfront payment of $50 million for.....